Syros Pharmaceuticals

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Located in Woburn, MA, Cardinal Health is a trusted pharmacy offering a wide range of healthcare products and services. Customers can expect a welcoming atmosphere and knowledgeable staff ready to assist with any medical needs. From prescription medications to over-the-counter remedies, this pharmacy strives to provide comprehensive care to all who walk through its doors. With a convenient location in Woburn, MA, Cardinal Health is a go-to destination for those seeking reliable pharmaceutical services. Patients can rely on this pharmacy for quick and efficient prescription fills, as well as expert advice on medication management. Whether you're picking up a refill or looking for guidance on a new treatment, Cardinal Health is dedicated to serving the community with top-notch care. Generated using this place's available information

AVEO Pharmaceuticals Inc. is an oncology-focused biopharmaceutical company based in Cambridge, MA, dedicated to developing innovative medicines aimed at improving the lives of cancer patients. The company is committed to pursuing advanced solutions in cancer treatment through its research and development efforts. As part of its mission, AVEO emphasizes a culture of collaboration and innovation, working closely with partners and scientific advisors to enhance its therapeutic offerings. The company is driven by a passion for delivering better outcomes for patients facing the challenges of cancer. Generated from the website